Age-Related Structural and Metabolic Changes in the Pelvic Reproductive End Organs

Seminars in Nuclear Medicine

Volumn 37, Issue 3, 2007, Pages 173-184

  Well, David ^a   Yang, Hua ^a   Houseni, Mohamed ^a   Iruvuri, Sireesha ^a   Alzeair, Saad ^a   Sansovini, Maddalena ^a   Wintering, Nancy ^a   Alavi, Abass ^a   Torigian, Drew A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMINAL SCINTISCANNING; ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LIFESPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY; PATHOPHYSIOLOGY; PELVIS; PELVIS SCINTISCANNING; PROSTATE; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SCROTUM; STRUCTURE ACTIVITY RELATION; TESTIS; TESTIS SIZE; UTERUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PROSTATE; UTERUS;

EID: 34047106728     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2007.01.004     Document Type: Article

References (135)

1. Tenover J.S. Declining testicular function in aging men. Int J Impot Res 4 suppl 15 (2003) S3-S8
2. Liu P.Y., Wishart S.M., and Handelsman D.J. A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab 87 (2002) 3125-3135
3. Elmlinger M.W., Kuhnel W., Wormstall H., et al. Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age. Clin Lab 51 (2005) 625-632
4. Elmlinger M.W., Kuhnel W., and Doller P.C. Evaluation of direct and indirect markers to assess the androgen status in healthy males during aging. Clin Lab 52 (2006) 491-496
5. Sowers M.R., Wilson A.L., Karvonen-Gutierrez C.A., et al. Sex steroid hormone pathway genes and health-related measures in women of 4 races/ethnicities: The Study of Women's Health Across the Nation (SWAN). Am J Med 119 (2006) S103-S110
6. Lerman H., Metser U., Grisaru D., et al. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J Nucl Med 45 (2004) 266-271
7. Meldrum D.R. Female reproductive aging-ovarian and uterine factors. Fertil Steril 59 (1993) 1-5
8. Magyar Z., and Fel T. [Treatment of menopausal symptoms-review of the current literature]. Orv Hetil 147 (2006) 879-885
9. Wu C.H. Current considerations of the menopause. Ann Clin Lab Sci 15 (1985) 219-228
10. Morse C.A., and Rice K. Memory after menopause: Preliminary considerations of hormone influence on cognitive functioning. Arch Womens Ment Health 8 (2005) 155-162
11. La Vecchia C. Sex hormones and cardiovascular risk. Hum Reprod 7 (1992) 162-167
12. Dalal D., and Robbins J.A. Management of hyperlipidemia in the elderly population: An evidence-based approach. South Med J 95 (2002) 1255-1261
13. Van Voorhis B.J. Genitourinary symptoms in the menopausal transition. Am J Med 118 suppl 12B (2005) 47-53
14. Fitzgerald C., Zimon A.E., and Jones E.E. Aging and reproductive potential in women. Yale J Biol Med 71 (1998) 367-381
15. Chakraborty T.R., and Gore A.C. Aging-related changes in ovarian hormones, their receptors, and neuroendocrine function. Exp Biol Med (Maywood) 229 (2004) 977-987
16. Kanaley J.A., Sames C., Swisher L., et al. Abdominal fat distribution in pre- and postmenopausal women: The impact of physical activity, age, and menopausal status. Metabolism 50 (2001) 976-982
17. Gore A.C., Oung T., and Woller M.J. Age-related changes in hypothalamic gonadotropin-releasing hormone and N-methyl-D-aspartate receptor gene expression, and their regulation by oestrogen, in the female rat. J Neuroendocrinol 14 (2002) 300-309
18. Polo-Kantola P., Saaresranta T., and Polo O. Aetiology and treatment of sleep disturbances during perimenopause and postmenopause. CNS Drugs 15 (2001) 445-452
19. Benitez del Castillo J.M., del Rio T., and Garcia-Sanchez J. Effects of estrogen use on lens transmittance in postmenopausal women. Ophthalmology 104 (1997) 970-973
20. Sipila S., Taaffe D.R., Cheng S., et al. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin Sci (Lond) 101 (2001) 147-157
21. Taskin O., Gokdeniz R., Muderrisoglu H., et al. The effects of hormone replacement therapy on echocardiographic basic cardiac functions in postmenopausal women. Hum Reprod 13 (1998) 2399-2401
22. Boccardi M., Ghidoni R., Govoni S., et al. Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study. Menopause 13 (2006) 584-591
23. Liang Y.L., Teede H., Shiel L.M., et al. Effects of oestrogen and progesterone on age-related changes in arteries of postmenopausal women. Clin Exp Pharmacol Physiol 24 (1997) 457-459
24. Rice M.M., Graves A.B., McCurry S.M., et al. Estrogen replacement therapy and cognitive function in postmenopausal women without dementia. Am J Med 103 (1997) 26S-35S
25. Straub R.H., Hense H.W., Andus T., et al. Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: A population-based study. J Clin Endocrinol Metab 85 (2000) 1340-1344
26. Compton J., van Amelsvoort T., and Murphy D. HRT and its effect on normal ageing of the brain and dementia. Br J Clin Pharmacol 52 (2001) 647-653
27. Hall J.E., Lavoie H.B., Marsh E.E., et al. Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women. J Clin Endocrinol Metab 85 (2000) 1794-1800
28. Gill S., Sharpless J.L., Rado K., et al. Evidence that GnRH decreases with gonadal steroid feedback but increases with age in postmenopausal women. J Clin Endocrinol Metab 87 (2002) 2290-2296
29. Reame N.E., Kelche R.P., Beitins I.Z., et al. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women. J Clin Endocrinol Metab 81 (1996) 1512-1518
30. Cano F., Simon C., Remohi J., et al. Effect of aging on the female reproductive system: Evidence for a role of uterine senescence in the decline in female fecundity. Fertil Steril 64 (1995) 584-589
31. Nalaboff K.M., Pellerito J.S., and Ben-Levi E. Imaging the endometrium: disease and normal variants. Radiographics 21 (2001) 1409-1424
32. Hauth EA, Jaeger HJ, Libera H, et al: MR imaging of the uterus and cervix in healthy women: Determination of normal values. Eur Radiol, in press
33. Herter L.D., Golendziner E., Flores J.A., et al. Ovarian and uterine sonography in healthy girls between 1 and 13 years old: Correlation of findings with age and pubertal status. AJR Am J Roentgenol 178 (2002) 1531-1536
34. Orbak Z., Sagsoz N., Alp H., et al. Pelvic ultrasound measurements in normal girls: Relation to puberty and sex hormone concentration. J Pediatr Endocrinol Metab 11 (1998) 525-530
35. Brown H.K., Stoll B.S., Nicosia S.V., et al. Uterine junctional zone: correlation between histologic findings and MR imaging. Radiology 179 (1991) 409-413
36. Haynor D.R., Mack L.A., Soules M.R., et al. Changing appearance of the normal uterus during the menstrual cycle: MR studies. Radiology 161 (1986) 459-462
37. Hoad C.L., Raine-Fenning N.J., Fulford J., et al. Uterine tissue development in healthy women during the normal menstrual cycle and investigations with magnetic resonance imaging. Am J Obstet Gynecol 192 (2005) 648-654
38. Larson S.M., Morris M., Gunther I., et al. Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer. J Nucl Med 45 (2004) 366-373
39. Mitchell D.G., Schonholz L., Hilpert P.L., et al. Zones of the uterus: discrepancy between US and MR images. Radiology 174 (1990) 827-831
40. Togashi K., Nakai A., and Sugimura K. Anatomy and physiology of the female pelvis: MR imaging revisited. J Magn Reson Imaging 13 (2001) 842-849
41. Demas B.E., Hricak H., and Jaffe R.B. Uterine MR imaging: Effects of hormonal stimulation. Radiology 159 (1986) 123-126
42. Goldstein S.R., Nachtigall M., Snyder J.R., et al. Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 163 (1990) 119-123
43. Karlsson B., Granberg S., Wikland M., et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding-a Nordic multicenter study. Am J Obstet Gynecol 172 (1995) 1488-1494
44. Karlsson B., Granberg S., Hellberg P., et al. Comparative study of transvaginal sonography and hysteroscopy for the detection of pathologic endometrial lesions in women with postmenopausal bleeding. J Ultrasound Med 13 (1994) 757-762
45. Smith-Bindman R., Kerlikowske K., Feldstein V.A., et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 280 (1998) 1510-1517
46. Gupta J.K., Chien P.F., Voit D., et al. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: A meta-analysis. Acta Obstet Gynecol Scand 81 (2002) 799-816
47. Grasel R.P., Outwater E.K., Siegelman E.S., et al. Endometrial polyps: MR imaging features and distinction from endometrial carcinoma. Radiology 214 (2000) 47-52
48. Kido A., Togashi K., Koyama T., et al. Diffusely enlarged uterus: Evaluation with MR imaging. Radiographics 23 (2003) 1423-1439
49. Reinhold C., Tafazoli F., Mehio A., et al. Uterine adenomyosis: Endovaginal US and MR imaging features with histopathologic correlation. Radiographics (1999) S147-S160 19 Spec No
50. Hricak H., Tscholakoff D., Heinrichs L., et al. Uterine leiomyomas: Correlation of MR, histopathologic findings, and symptoms. Radiology 158 (1986) 385-391
51. Merz E., Miric-Tesanic D., Bahlmann F., et al. Sonographic size of uterus and ovaries in pre- and postmenopausal women. Ultrasound Obstet Gynecol 7 (1996) 38-42
52. Nishizawa S., Inubushi M., and Okada H. Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers. Eur J Nucl Med Mol Imaging 32 (2005) 549-556
53. Cohen H.L., Tice H.M., and Mandel F.S. Ovarian volumes measured by US: Bigger than we think. Radiology 177 (1990) 189-192
54. Haber H.P., and Mayer E.I. Ultrasound evaluation of uterine and ovarian size from birth to puberty. Pediatr Radiol 24 (1994) 11-13
55. Giacobbe M., Pinto-Neto A.M., Costa-Paiva L.H., et al. Ovarian volume, age, and menopausal status. Menopause 11 (2004) 180-185
56. Goswamy R.K., Campbell S., Royston J.P., et al. Ovarian size in postmenopausal women. Br J Obstet Gynaecol 95 (1988) 795-801
57. Granberg S., and Wikland M. A comparison between ultrasound and gynecologic examination for detection of enlarged ovaries in a group of women at risk for ovarian carcinoma. J Ultrasound Med 7 (1988) 59-64
58. Christensen J.T., Boldsen J., and Westergaard J.G. Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraception. Acta Obstet Gynecol Scand 76 (1997) 784-789
59. Cottrill H.M., Fitzcharles E.K., and Modesitt S.C. Positron emission tomography in a premenopausal asymptomatic woman: A case report of increased ovarian uptake in a benign condition. Int J Gynecol Cancer 15 (2005) 1127-1130
60. Kim S.K., Kang K.W., Roh J.W., et al. Incidental ovarian 18F-FDG accumulation on PET: Correlation with the menstrual cycle. Eur J Nucl Med Mol Imaging 32 (2005) 757-763
61. Short S., Hoskin P., and Wong W. Ovulation and increased FDG uptake on PET: Potential for a false-positive result. Clin Nucl Med 30 (2005) 707
62. Zgliczynski S. [Menopause and andropause as a public health problem]. Pol Tyg Lek 50 (1995) 3-4
63. Wu C.Y., Yu T.J., and Chen M.J. Age related testosterone level changes and male andropause syndrome. Chang Gung Med J 23 (2000) 348-353
64. Tenover J.L. Male hormone replacement therapy including "andropause.". Endocrinol Metab Clin North Am 27 (1998) 969-987 x
65. Yialamas M.A., and Hayes F.J. Androgens and the ageing male and female. Best Pract Res Clin Endocrinol Metab 17 (2003) 223-236
66. Chanson P., Young J., and Bry H. [Menopause and andropause]. Rev Prat 54 (2004) 985-990
67. Wyllie M.G. ADAM and the andropause. BJU Int 91 (2003) 883-884
68. Morley J.E., Korenman S.G., Mooradian A.D., et al. Sexual dysfunction in the elderly male. J Am Geriatr Soc 35 (1987) 1014-1022
69. Morley J.E., and Kaiser F.E. Sexual function with advancing age. Med Clin North Am 73 (1989) 1483-1495
70. Forbes G.B. Longitudinal changes in adult body composition: Influence of body weight. Appl Radiat Isot 49 (1998) 571-573
71. Stellato R.K., Feldman H.A., Hamdy O., et al. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23 (2000) 490-494
72. Meier D.E., Orwoll E.S., Keenan E.J., et al. Marked decline in trabecular bone mineral content in healthy men with age: Lack of association with sex steroid levels. J Am Geriatr Soc 35 (1987) 189-197
73. Orwoll E., Ettinger M., Weiss S., et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med 343 (2000) 604-610
74. Janowsky J.S., Chavez B., and Orwoll E. Sex steroids modify working memory. J Cogn Neurosci 12 (2000) 407-414
75. Wilson M.M., and Morley J.E. Invited review: Aging and energy balance. J Appl Physiol 95 (2003) 1728-1736
76. Morley J.E. Commentary: Geriatric future history. J Nutr Health Aging 10 (2006) 431
77. Morley J.E. Andropause: Is it time for the geriatrician to treat it?. J Gerontol A Biol Sci Med Sci 56 (2001) M263-M265
78. Morley J.E. Anorexia, body composition, and ageing. Curr Opin Clin Nutr Metab Care 4 (2001) 9-13
79. Thompson C.A., Shanafelt T.D., and Loprinzi C.L. Andropause: Symptom management for prostate cancer patients treated with hormonal ablation. Oncologist 8 (2003) 474-487
80. Auger J., and Jouannet P. Age and male fertility: biological factors. Rev Epidemiol Sante Publique (2005) 53 Spec No 2:2S25-35
81. Johnson L. Evaluation of the human testis and its age-related dysfunction. Prog Clin Biol Res 302 (1989) 35-60 discussion 61-37
82. Gray A., Feldman H.A., McKinlay J.B., et al. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 73 (1991) 1016-1025
83. Gray D.S., and Gorzalka B.B. Adrenal steroid interactions in female sexual behavior: A review. Psychoneuroendocrinology 5 (1980) 157-175
84. Feldman H.A., Longcope C., Derby C.A., et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87 (2002) 589-598
85. Harman S.M., Metter E.J., Tobin J.D., et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86 (2001) 724-731
86. Morley J.E., Kaiser F.E., Sih R., et al. Testosterone and frailty. Clin Geriatr Med 13 (1997) 685-695
87. Carreau S., Bourguiba S., and Marie E. Testicular and blood steroid levels in aged men. Reprod Biol 4 (2004) 299-304
88. Beres J., Papp G., Pazonyi I., et al. Testicular volume variations from 0 to 28 years of age. Int Urol Nephrol 21 (1989) 159-167
89. Chin T., Liu C., and Wei C. Testicular volume in Taiwanese boys. Zhonghua Yi Xue Za Zhi (Taipei) 61 (1998) 29-33
90. Matsuo N., Anzo M., Sato S., et al. Testicular volume in Japanese boys up to the age of 15 years. Eur J Pediatr 159 (2000) 843-845
91. Hamm B., and Fobbe F. Maturation of the testis: ultrasound evaluation. Ultrasound Med Biol 21 (1995) 143-147
92. Paltiel H.J., Rupich R.C., and Babcock D.S. Maturational changes in arterial impedance of the normal testis in boys: Doppler sonographic study. AJR Am J Roentgenol 163 (1994) 1189-1193
93. Ng K.K., Donat R., Chan L., et al. Sperm output of older men. Hum Reprod 19 (2004) 1811-1815
94. Pasqualotto F.F., Sobreiro B.P., Hallak J., et al. Sperm concentration and normal sperm morphology decrease and follicle-stimulating hormone level increases with age. BJU Int 96 (2005) 1087-1091
95. Ford W.C., North K., Taylor H., et al., The ALSPAC Study Team (Avon Longitudinal Study of Pregnancy and Childhood). Increasing paternal age is associated with delayed conception in a large population of fertile couples: evidence for declining fecundity in older men. Hum Reprod 15 (2000) 1703-1708
96. Kidd S.A., Eskenazi B., and Wyrobek A.J. Effects of male age on semen quality and fertility: A review of the literature. Fertil Steril 75 (2001) 237-248
97. Kuhnert B., and Nieschlag E. Reproductive functions of the ageing male. Hum Reprod Update 10 (2004) 327-339
98. Eberling J.L., Wu C., Haan M.N., et al. Preliminary evidence that estrogen protects against age-related hippocampal atrophy. Neurobiol Aging 24 (2003) 725-732
99. Hassan M.A., and Killick S.R. Effect of male age on fertility: evidence for the decline in male fertility with increasing age. Fertil Steril 79 suppl 3 (2003) 1520-1527
100. Homonnai Z.T., Fainman N., David M.P., et al. Semen quality and sex hormone pattern of 29 middle aged men. Andrologia 14 (1982) 164-170
101. Neaves W.B., Johnson L., Porter J.C., et al. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab 59 (1984) 756-763
102. Johnson L., Zane R.S., Petty C.S., et al. Quantification of the human Sertoli cell population: Its distribution, relation to germ cell numbers, and age-related decline. Biol Reprod 31 (1984) 785-795
103. Handelsman D.J., and Staraj S. Testicular size: The effects of aging, malnutrition, and illness. J Androl 6 (1985) 144-151
104. Mahmoud A.M., Goemaere S., El-Garem Y., et al. Testicular volume in relation to hormonal indices of gonadal function in community-dwelling elderly men. J Clin Endocrinol Metab 88 (2003) 179-184
105. Kosuda S., Fisher S., Kison P.V., et al. Uptake of 2-deoxy-2-[18F]fluoro-D-glucose in the normal testis: retrospective PET study and animal experiment. Ann Nucl Med 11 (1997) 195-199
106. Wolf G., Aigner R.M., Schwarz T., et al. Diagnosis of a contralateral second testicular carcinoma by F18-FDG PET. Onkologie 26 (2003) 155-157
107. Bosch J.L., Hop W.C., Niemer A.Q., et al. Parameters of prostate volume and shape in a community based population of men 55 to 74 years old. J Urol 152 (1994) 1501-1505
108. Berry S.J., Coffey D.S., Walsh P.C., et al. The development of human benign prostatic hyperplasia with age. J Urol 132 (1984) 474-479
109. Untergasser G., Madersbacher S., and Berger P. Benign prostatic hyperplasia: Age-related tissue-remodeling. Exp Gerontol 40 (2005) 121-128
110. Sagel J., Distiller L.A., Morley J.E., et al. Myotonia dystrophica: Studies on gonadal function using luteinizing hormone-releasing hormone (LRH). J Clin Endocrinol Metab 40 (1975) 1110-1113
111. McNeal J.E. The zonal anatomy of the prostate. Prostate 2 (1981) 35-49
112. Tolley D.A., and Castro J.E. Hemospermia. Urology 6 (1975) 331-332
113. Rifkin M.D., Dahnert W., and Kurtz A.B. State of the art: Endorectal sonography of the prostate gland. AJR Am J Roentgenol 154 (1990) 691-700
114. Torigian DA, Ramchandani P: Hematospermia: Imaging findings. Abdom Imaging, in press
115. Arenas M.I., Romo E., Royuela M., et al. Morphometric evaluation of the human prostate. Int J Androl 24 (2001) 37-47
116. Bartsch G., Rittmaster R.S., and Klocker H. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. World J Urol 19 (2002) 413-425
117. Bostwick D.G., Cooner W.H., Denis L., et al. The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 70 (1992) 291-301
118. Jungblut T., Aumuller G., Malek B., et al. Age-dependency and regional distribution of enkephalinergic nerves in human prostate. Urol Int 44 (1989) 352-356
119. Burnett A.L., Maguire M.P., Chamness S.L., et al. Characterization and localization of nitric oxide synthase in the human prostate. Urology 45 (1995) 435-439
120. Crone J.K., Burnett A.L., Chamness S.L., et al. Neuronal nitric oxide synthase in the canine prostate: Aging, sex steroid, and pathology correlations. J Androl 19 (1998) 358-364
121. Takeda M., Tang R., Shapiro E., et al. Effects of nitric oxide on human and canine prostates. Urology 45 (1995) 440-446
122. Roberts R.O., Jacobson D.J., Rhodes T., et al. Serum sex hormones and measures of benign prostatic hyperplasia. Prostate 61 (2004) 124-131
123. Shibata Y., Ito K., Suzuki K., et al. Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition. Prostate 42 (2000) 45-55
124. Silver R.I., Wiley E.L., Thigpen A.E., et al. Cell type specific expression of steroid 5 alpha-reductase 2. J Urol 152 (1994) 438-442
125. Allen K.S., Kressel H.Y., Arger P.H., et al. Age-related changes of the prostate: evaluation by MR imaging. AJR Am J Roentgenol 152 (1989) 77-81
126. Williams A.M., Simon I., Landis P.K., et al. Prostatic growth rate determined from MRI data: Age-related longitudinal changes. J Androl 20 (1999) 474-480
127. Vesely S., Knutson T., Damber J.E., et al. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. Scand J Urol Nephrol 37 (2003) 322-328
128. Zackrisson B., Hugosson J., and Aus G. Transrectal ultrasound anatomy of the prostate and seminal vesicles in healthy men. Scand J Urol Nephrol 34 (2000) 175-180
129. Jakobsen H., Torp-Pedersen S., and Juul N. Ultrasonic evaluation of age-related human prostatic growth and development of benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 107 (1988) 26-31
130. Xia S.J., Xu X.X., Teng J.B., et al. Characteristic pattern of human prostatic growth with age. Asian J Androl 4 (2002) 269-271
131. Jacobsen S.J., Jacobson D.J., Girman C.J., et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol 158 (1997) 481-487
132. Morote J., Encabo G., Lopez M., et al. Prediction of prostate volume based on total and free serum prostate-specific antigen: Is it reliable?. Eur Urol 38 (2000) 91-95
133. Roehrborn C.G., Boyle P., Gould A.L., et al. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 53 (1999) 581-589
134. Uygur M.C., Erol D., Cetinkaya M., et al. The correlation between prostate-specific antigen and age. Analysis of prostate-specific antigen values from 4,846 Turkish men with symptomatic benign prostatic hyperplasia. Eur Urol 32 (1997) 416-419
135. Ezz el Din K., Kiemeney L.A., de Wildt M.J., et al. Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score. Urology 48 (1996) 393-397